Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV7909 Liquid vs Lyophilized in Healthy Adults
NCT04660201Phase 1Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2022
- Primary completion
- Nov 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of NuThrax in anthrax (2 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoints: Serious Adverse Events and Solicited Injection Site and Systemic Reactogenicity Events. Started May 2022; status: completed.
02
Drugs
NuThrax
03
Conditions
anthrax
Beyond the preview
Go deeper on NCT04660201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04660201.